Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods is a research paper published in Genetics in Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Cancer Institute
Grant: 1R01HG009694-01
National Cancer Institute
Grant: K99HG011491
National Cancer Institute
Grant: U01 HG006485
National Cancer Institute
Grant: U01 HG006487
National Cancer Institute
Grant: U01 HG007301
National Cancer Institute
Grant: U01 HG009599
National Cancer Institute
Grant: U01 HG009610
National Cancer Institute
Grant: U01 HG007292
National Cancer Institute
Grant: U24HG007307
NHGRI NIH HHS
Grant: R01 HG009694
National Institutes of Health
Foundation Medicine
National Institute on Minority Health and Health Disparities
National Human Genome Research Institute
Fields of Study
MeSH Terms
Keywords